ESC 365 - NLRP3/IL-1 pathway was reduced by semaglutide and dapagliflozin in association therapy under exposure to anthracyclines in hyperglycemic conditions

ESC2025 Premium Access

NLRP3/IL-1 pathway was reduced by semaglutide and dapagliflozin in association therapy under exposure to anthracyclines in hyperglycemic conditions

Session: Cardio-oncology and therapy

Topic: Cardio-Oncology

Speaker: Doctor N. Maurea (Naples, IT)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Nicola Maurea

National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)

3 presentations

2 followers

3 more presentations in this session

Age- and sex-specific association between clonal hematopoiesis of indeterminate potential and pulmonary hypertension

Speaker: Doctor G. Sun (Guangzhou, CN)

Variability in echocardiographic surveillance for cardiotoxicity in HER2+ versus HER2- breast cancer: a SEER-medicare analysis

Speaker: Associate Professor J. Strom (Boston, US)

The role of TAK1 inhibition in doxorubicin-induced cardiotoxicity: an in vitro study

Speaker: Associate Professor B. Polegato (Botucatu, BR)

Access the full session

Cardio-oncology and therapy

Speakers: Doctor N. Maurea, Doctor G. Sun, Associate Professor J. Strom, Associate Professor B. Polegato

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources